How to Interpret a Positive ANA
| ANA Titre | Clinical Significance |
|---|---|
| 1:40 | Very common in healthy people: low significance alone |
| 1:80 | Borderline: consider clinical context |
| 1:160 | Clinically significant: warrants further investigation with ENA panel |
| ≥1:320 | Strongly positive: high probability of autoimmune disease |
ANA Pattern and Associated Diseases
| ANA Pattern | Associated Antibody | Condition |
|---|---|---|
| Homogeneous (diffuse) | Anti-dsDNA, anti-histone | SLE, drug-induced lupus |
| Speckled | Anti-Sm, anti-SSA/Ro, anti-SSB/La, anti-Scl70 | SLE, Sjögren's, scleroderma, MCTD |
| Nucleolar | Anti-Scl70, anti-PM-Scl | Systemic sclerosis |
| Centromere | Anti-centromere | Limited scleroderma (CREST) |
ENA Panel Follows Positive ANA
If ANA is positive at ≥1:160, an extractable nuclear antigen (ENA) panel is ordered: anti-dsDNA, anti-Sm, anti-SSA/Ro, anti-SSB/La, anti-Scl-70, anti-Jo-1, anti-centromere. These more specific antibodies guide diagnosis.
References
The clinical information on this page is based on peer-reviewed sources indexed in PubMed, the biomedical literature database of the US National Library of Medicine.
- Satoh M, Chan EKL, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012;64(7):2319-27. doi:10.1002/art.34380 · PMID 22354543
Related reading
- Guide to Autoimmune Blood TestsWhat blood tests diagnose autoimmune diseases? Learn about ANA…
- Lupus (SLE): Diagnosis & Treatment GuideComplete guide to systemic lupus erythematosus: symptoms, diagnostic…
- Rheumatoid Factor (RF) Blood TestWhat does a positive rheumatoid factor (RF) blood test mean? Normal…
- Anti-CCP & Rheumatoid Factor: Rheumatoid Arthritis TestsAnti-CCP and rheumatoid factor are the key blood tests for diagnosing…
- Widal TestWhat does a positive Widal test mean? Understand Widal test titres…
- Multiple Sclerosis (MS)What blood tests are done for multiple sclerosis? Learn how MS is…
A positive ANA is common in healthy people
This is the single most important thing to understand about the test. Depending on the cut-off used, roughly 10 to 15 per cent of entirely healthy people have a positive ANA at 1:80, and the proportion rises with age and is higher in women. A positive result in someone without symptoms therefore has a low probability of indicating disease. This is why the test performs badly as a screen and why guidelines discourage ordering it in the absence of clinical features suggesting connective tissue disease.
The corollary matters too: because so many well people test positive, an unexplained positive ANA frequently causes considerable anxiety and leads to further testing that finds nothing. Where a result has already been obtained without a clear indication, the sensible interpretation is to weigh it against the clinical picture rather than to pursue it in isolation.
Titre changes what the result means
- 1:40 to 1:80 is weakly positive and frequently seen in healthy individuals.
- 1:160 is moderately positive and warrants correlation with symptoms.
- 1:320 and above is more likely to be clinically significant, particularly with a defined pattern.
Titres are reported as doubling dilutions, so each step represents a twofold change. A shift from 1:160 to 1:320 is one dilution and may reflect assay variation rather than disease activity, which is why ANA titres are not used to monitor established disease.
What follows a meaningful positive
Where the clinical picture supports it, the next step is specific antibody testing rather than repeating the ANA: anti-dsDNA and anti-Sm for lupus, anti-Ro and anti-La for Sjögren's, anti-centromere and anti-Scl-70 for systemic sclerosis, anti-Jo-1 for myositis. Complement levels, urinalysis for protein and blood, and a full blood count are usually checked at the same time, since organ involvement matters more than serology. A negative ANA makes lupus unlikely but does not exclude every connective tissue disease, and some conditions are ANA-negative by nature.